Watch Ticker

GH Research PLC Ordinary Shares

Go to GH Research PLC Ordinary Shares Website

$13.06

0.00 (0.00%)

Live

Previous Close

$13.06

Day Range

$0 - $0

Previous Day Range

$12.975 - $13.6

Market Cap

$833.7 million USD

Day Vol.

Previous Day Vol.

227186

Currency

USD

Primary Exchange

Nasdaq

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Gh Research Plc - GH Research Announces Global Pivotal Program Plans and Further Development Updates

GH Research submitted a complete response to FDA's clinical hold on GH001, with one remaining issue regarding respiratory tract histology in rats. The Phase 2b trial showed a 73% remission rate at 6 months for treatment-resistant depression, with no serious adverse events and promising treatment outcomes.

Related tickers: GHRS.

Read Full Article

N/A - GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule

GH Research PLC, a clinical-stage biopharmaceutical company, announced the submission of its complete response to the FDA regarding the clinical hold on its Investigational New Drug Application for GH001, its lead product candidate for treating treatment-resistant depression.

Related tickers: GHRS.

Read Full Article

Trending Tickers

Please sign in to view